XLRN

Acceleron Pharma Inc.
XLRN

Overview Fund Activity
Delisted

XLRN was delisted on the 19th of November, 2021.

Back to rankings

171 hedge funds and large institutions have $2.3B invested in Acceleron Pharma Inc. in 2019 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 74 increasing their positions, 45 reducing their positions, and 18 closing their positions.

Holders
171
Holders Change
+9
Holders Change %
+5.56%
% of All Funds
3.71%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.07%
New
28
Increased
74
Reduced
45
Closed
18
Calls
$17.5M
Puts
$15.2M
Net Calls
+$2.29M
Net Calls Change
-$21.2M

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$68.4M
2
AG
2
Artal Group
Luxembourg
$76.8M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$187M
4
Alkeon Capital Management
4
Alkeon Capital Management
New York
$39.3M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$343M

Top Sellers

1
PA
1
Perceptive Advisors
New York
$0
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$209M
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$0
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$23.2M
5
NHAS
5
Novo Holdings A/S
Denmark
$9.23M
Name Holding Trade Value Shares
Change 		Shares
Change %
Brown Advisory
26
Brown Advisory
Maryland
$16.9M +$1.89M +40,483 +13%
UBS AM
27
UBS AM
Illinois
$16.1M -$231K -4,955 -1%
DekaBank Deutsche Girozentrale
28
DekaBank Deutsche Girozentrale
Germany
$15.7M +$4.13M +76,700 +36%
Axa
29
Axa
France
$14M +$10.8M +231,579 +337%
PAMU
30
Pictet Asset Management (UK)
United Kingdom
$13.3M +$122K +2,609 +0.9%
SAM
31
Sectoral Asset Management
Quebec, Canada
$12.5M +$2.69M +57,670 +27%
FCMI
32
Foresite Capital Management III
California
$11.9M +$887K +19,055 +8%
Charles Schwab
33
Charles Schwab
California
$11.5M +$1.59M +34,182 +16%
CS
34
Candriam SCA
Luxembourg
$11.2M -$105K -2,258 -0.9%
GIM
35
Granahan Investment Management
Massachusetts
$10.2M -$686K -14,738 -6%
Marshall Wace
36
Marshall Wace
United Kingdom
$9.7M +$9.65M +207,304 +20,146%
NHAS
37
Novo Holdings A/S
Denmark
$9.23M -$10.3M -222,032 -53%
QF
38
QVT Financial
New York
$8.89M – – –
FCMI
39
Foresite Capital Management II
California
$8.78M -$978K -21,000 -10%
TCM
40
Tekla Capital Management
Massachusetts
$8.77M +$821K +17,622 +10%
Hudson Bay Capital Management
41
Hudson Bay Capital Management
Connecticut
$8.62M +$931K +20,000 +12%
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$7.76M +$907K +19,475 +13%
UBS Group
43
UBS Group
Switzerland
$7.38M -$5.03M -108,102 -41%
Principal Financial Group
44
Principal Financial Group
Iowa
$6.77M +$198K +4,256 +3%
Citadel Advisors
45
Citadel Advisors
Florida
$6.34M +$6.34M +136,143 New
EAM
46
Eventide Asset Management
Massachusetts
$6M – – –
Bank of America
47
Bank of America
North Carolina
$5.87M +$3.53M +75,811 +151%
AA
48
ALPS Advisors
Colorado
$5.8M +$826K +17,744 +17%
BAMCO Inc
49
BAMCO Inc
New York
$5.62M +$2.35M +50,446 +72%
Two Sigma Investments
50
Two Sigma Investments
New York
$5.57M +$5.57M +119,687 New
1
2
3 4 5